Literature DB >> 9529613

SMADs: mediators and regulators of TGF-beta signaling.

M Kretzschmar1, J Massagué.   

Abstract

The discovery of SMAD proteins has allowed the delineation of a mechanism by which TGF-beta and related growth factors convey their signals from membrane receptors all the way into the nucleus. SMADs are directly phosphorylated and activated by the receptors and then form heteromeric SMAD-SMAD complexes that move into the nucleus where they orchestrate transcriptional responses. In rapid succession, recent reports have identified different modes of SMAD regulation by phosphorylation and have defined the SMAD domains that mediate SMAD interactions, binding to DNA or transcriptional activation. The recent discovery of antagonistic SMADs and regulatory crosstalk with Ras/MAP-kinase pathways add to our rapidly expanding understanding of this major regulatory network.

Mesh:

Substances:

Year:  1998        PMID: 9529613     DOI: 10.1016/s0959-437x(98)80069-5

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  103 in total

1.  Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31.

Authors:  G Feldman; M Li; S Martin; M Urbanek; J A Urtizberea; M Fardeau; M LeMerrer; J M Connor; J Triffitt; R Smith; M Muenke; F S Kaplan; E M Shore
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Exocyst is involved in cystogenesis and tubulogenesis and acts by modulating synthesis and delivery of basolateral plasma membrane and secretory proteins.

Authors:  J H Lipschutz; W Guo; L E O'Brien; Y H Nguyen; P Novick; K E Mostov
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

3.  A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.

Authors:  M Bitzer; G von Gersdorff; D Liang; A Dominguez-Rosales; A A Beg; M Rojkind; E P Böttinger
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

4.  TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest.

Authors:  Neil A Bhowmick; Mayshan Ghiassi; Mary Aakre; Kimberly Brown; Vikas Singh; Harold L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

5.  Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.

Authors:  M A Lynch; T A Petrel; H Song; T J Knobloch; B C Casto; D Ramljak; L M Anderson; V DeGroff; G D Stoner; R W Brueggemeier; C M Weghorst
Journal:  Gene Expr       Date:  2001

6.  BMP type I receptor ALK2 is essential for proper patterning at late gastrulation during mouse embryogenesis.

Authors:  Yoshihiro Komatsu; Gregory Scott; Andre Nagy; Vesa Kaartinen; Yuji Mishina
Journal:  Dev Dyn       Date:  2007-02       Impact factor: 3.780

Review 7.  Reversal of tumor-induced immunosuppression by TGF-beta inhibitors.

Authors:  Slawomir Wojtowicz-Praga
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

8.  Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.

Authors:  Chun-Cheng Hou; Wansheng Wang; Xiao R Huang; Ping Fu; Tso-Hsiao Chen; David Sheikh-Hamad; Hui Y Lan
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

9.  Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6.

Authors:  Toru Ogasawara; Hiroshi Kawaguchi; Shigeki Jinno; Kazuto Hoshi; Keiji Itaka; Tsuyoshi Takato; Kozo Nakamura; Hiroto Okayama
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve Development.

Authors:  Katelynn Toomer; Kimberly Sauls; Diana Fulmer; Lilong Guo; Kelsey Moore; Janiece Glover; Rebecca Stairley; Joyce Bischoff; Robert A Levine; Russell A Norris
Journal:  Anat Rec (Hoboken)       Date:  2018-10-05       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.